TMCnet News
Research and Markets: Systemic Juvenile Idiopathic Arthritis (SJIA) - Pipeline Review, H1 2014 ReportDUBLIN --(Business Wire)-- Research and Markets (http://www.researchandmarkets.com/research/c8bdzr/systemic_juvenile) has announced the addition of the "Systemic Juvenile Idiopathic Arthritis (SJIA) - Pipeline Review, H1 2014" report to their offering. 'Systemic Juvenile Idiopathic Arthritis (SJIA) - Pipeline Review, H1 2014', provides an overview of the indication's therapeutic pipeline. This report provides information on the therapeutic development for Systemic Juvenile Idiopathic Arthritis (SJIA), complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Systemic Juvenile Idiopathic Arthritis (SJIA). Systemic Juvenile Idiopathic Arthritis (SJIA) - Pipeline Review, Half Year is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC (News - Alert) filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Scope - A snapshot of the global therapeutic scenario for Systemic Juvenile Idiopathic Arthritis (SJIA). - A review of the Systemic Juvenile Idiopathic Arthritis (SJIA) products under development by companies and universities/research institutes based on information derived from company and industry-specific sources. - Coverage of products based on various stages of development ranging from discovery till registration stages. - A feature on pipeline projects on the basis of monotherapy and combined therapeutics. - Coverage of the Systemic Juvenile Idiopathic Arthritis (SJIA) pipeline on the basis of route of administration and molecule type. - Key discontinued pipeline projects. - Latest news and deals relating to the products. Key Topics Covered: List of Tables List of Figures Introduction Systemic Juvenile Idiopathic Arthritis (SJIA) Overview Pipeline Products for Systemic Juvenile Idiopathic Arthritis (SJIA) - Overview Late Stage Products Clinical Stage Products Early Stage Products Systemic Juvenile Idiopathic Arthritis (SJIA) - Products under Development by Companies Systemic Juvenile Idiopathic Arthritis (SJIA) - Therapeutics Assessment Drug Profiles abatacept - Drug Profile golimumab - Drug Profile givinostat - Drug Profile etanercept biosimilar - Drug Profile adalimumab biosimilar - Drug Profile Systemic Juvenile Idiopathic Arthritis (SJIA) - Recent Pipeline Updates Featured News & Press Releases Appendix Companies Mentioned Bristol-Myers Squibb Company Johnson & Johnson Biocon Limited Italfarmaco S.p.A. Avesthagen Limited For more information visit http://www.researchandmarkets.com/research/c8bdzr/systemic_juvenile About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
|